NFA
BLUE

Nuveen Fund Advisors’s bluebird bio BLUE Stock Holding History

Nuveen Fund Advisors’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-174
Closed -$205K – 423
2017
Q1 		$205K Buy
+174
New +$177K 0.03% 420

Other funds holding BLUE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Nuveen Fund Advisors's BLUE Position: Q2 2017 in Review

Nuveen Fund Advisors sold out of bluebird bio (BLUE) in Q2 2017, closing a stake of 174 shares — an estimated $205K sold.

Nuveen Fund Advisors first reported a position in BLUE in Q1 2017 and held it in 1 quarter. The position peaked at $205K in Q1 2017. 241 funds tracked by Wall St. Rank hold BLUE as of Q2 2017.

  • Nuveen Fund Advisors reported no remaining bluebird bio position as of Q2 2017 after selling out during the quarter.
  • Nuveen Fund Advisors sold 174 bluebird bio shares in Q2 2017, an estimated $205K.
  • Nuveen Fund Advisors first reported a position in bluebird bio in Q1 2017 and held it in 1 quarter.
  • Nuveen Fund Advisors's bluebird bio position peaked at $205K in Q1 2017.
  • 241 funds tracked by Wall St. Rank held bluebird bio as of Q2 2017.

Based on Nuveen Fund Advisors's 13F filing for Q2 2017, filed 14 Aug 2017.